An observational study in Meningitis, sponsored by Sohag University. Not yet recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-08-17.
Sponsored by Sohag University · Observational
analyze the clinical characteristics and prognostic factors in patients with meningitis at Sohag Governorate .This is an ambidirectional (retrospective and prospective), hospital-based observational study. The study involves a retrospective review of patient records over the past 3 years, combined with a prospective recruitment of new patients for one year from the initiation of the study
All patients diagnosed with meningitis and admitted to Sohag Fever Hospital during the study period, regardless of age or sex, who meet the study eligibility criteria.
Exclusion Criteria:
All-cause in-hospital mortality
Death from any cause occurring during hospitalization, reported as the number and percentage of participants who died during hospital admission.
Time frame: From hospital admission until hospital discharge, up to 30 days.
Recovery without neurological sequelae at hospital discharge
Number and percentage of participants who recover from meningitis without documented neurological sequelae at hospital discharge.
Time frame: From hospital admission until hospital discharge, up to 30 days.
Neurological sequelae at hospital discharge
Number and percentage of participants with documented neurological sequelae related to meningitis at hospital discharge.
Time frame: From hospital admission until hospital discharge, up to 30 days.
In-hospital complications
Number and percentage of participants who develop complications during hospitalization, with the type of complication recorded.
Time frame: From hospital admission until hospital discharge, up to 30 days.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sohag University